375 related articles for article (PubMed ID: 22633301)
1. Hypo- and hyperglycemia predict outcome in patients with left ventricular dysfunction after acute myocardial infarction: data from EPHESUS.
Ukena C; Dobre D; Mahfoud F; Kindermann I; Lamiral Z; Tala S; Rossignol P; Turgonyi E; Pitt B; Böhm M; Zannad F
J Card Fail; 2012 Jun; 18(6):439-45. PubMed ID: 22633301
[TBL] [Abstract][Full Text] [Related]
2. Extracellular cardiac matrix biomarkers in patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study.
Iraqi W; Rossignol P; Angioi M; Fay R; Nuée J; Ketelslegers JM; Vincent J; Pitt B; Zannad F
Circulation; 2009 May; 119(18):2471-9. PubMed ID: 19398668
[TBL] [Abstract][Full Text] [Related]
3. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.
Pitt B; Remme W; Zannad F; Neaton J; Martinez F; Roniker B; Bittman R; Hurley S; Kleiman J; Gatlin M;
N Engl J Med; 2003 Apr; 348(14):1309-21. PubMed ID: 12668699
[TBL] [Abstract][Full Text] [Related]
4. Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS).
Pitt B; Bakris G; Ruilope LM; DiCarlo L; Mukherjee R;
Circulation; 2008 Oct; 118(16):1643-50. PubMed ID: 18824643
[TBL] [Abstract][Full Text] [Related]
5. Eplerenone improves prognosis in postmyocardial infarction diabetic patients with heart failure: results from EPHESUS.
O'Keefe JH; Abuissa H; Pitt B
Diabetes Obes Metab; 2008 Jun; 10(6):492-7. PubMed ID: 17490427
[TBL] [Abstract][Full Text] [Related]
6. Heart failure with systolic dysfunction complicating acute myocardial infarction - differential outcomes but similar eplerenone efficacy by ST-segment or non-ST-segment elevation: A post hoc substudy of the EPHESUS trial.
Carillo S; Zhang Y; Fay R; Angioi M; Vincent J; Sutradhor SC; Ahmed A; Pitt B; Zannad F
Arch Cardiovasc Dis; 2014 Mar; 107(3):149-57. PubMed ID: 24630753
[TBL] [Abstract][Full Text] [Related]
7. Differential clinical outcomes associated with hypoglycemia and hyperglycemia in acute myocardial infarction.
Goyal A; Mehta SR; Díaz R; Gerstein HC; Afzal R; Xavier D; Liu L; Pais P; Yusuf S
Circulation; 2009 Dec; 120(24):2429-37. PubMed ID: 19948980
[TBL] [Abstract][Full Text] [Related]
8. [The role of diabetes mellitus as a risk factor of acute myocardial infarction].
Peng XR; Zhao YF; Zou DJ; Gu P
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Jun; 23(6):322-8. PubMed ID: 21672377
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of abnormal heart rate turbulence to predict cardiovascular mortality in high-risk patients with acute myocardial infarction and left ventricular dysfunction (from the EPHESUS study).
Stein PK; Deedwania P
Am J Cardiol; 2009 Jun; 103(11):1495-9. PubMed ID: 19463505
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of aldosterone blockade with eplerenone in patients with heart failure after acute myocardial infarction in the French context: the EPHESUS study.
de Pouvourville G; Solesse A; Beillat M
Arch Cardiovasc Dis; 2008 Sep; 101(9):515-21. PubMed ID: 19041835
[TBL] [Abstract][Full Text] [Related]
11. Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure.
Pitt B; White H; Nicolau J; Martinez F; Gheorghiade M; Aschermann M; van Veldhuisen DJ; Zannad F; Krum H; Mukherjee R; Vincent J;
J Am Coll Cardiol; 2005 Aug; 46(3):425-31. PubMed ID: 16053953
[TBL] [Abstract][Full Text] [Related]
12. Statin therapy and clinical outcomes in myocardial infarction patients complicated by acute heart failure: insights from the EPHESUS trial.
Dobre D; Rossignol P; Murin J; Parkhomenko A; Lamiral Z; Krum H; van Veldhuisen DJ; Pitt B; Zannad F
Eur J Heart Fail; 2013 Feb; 15(2):221-7. PubMed ID: 22872593
[TBL] [Abstract][Full Text] [Related]
13. The effects of eplerenone on length of stay and total days of heart failure hospitalization after myocardial infarction in patients with left ventricular systolic dysfunction.
Gheorghiade M; Khan S; Blair JE; Harinstein ME; Krum H; Mukherjee R; Pitt B;
Am Heart J; 2009 Sep; 158(3):437-43. PubMed ID: 19699868
[TBL] [Abstract][Full Text] [Related]
14. Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy.
Rossignol P; Ménard J; Fay R; Gustafsson F; Pitt B; Zannad F
J Am Coll Cardiol; 2011 Nov; 58(19):1958-66. PubMed ID: 22032706
[TBL] [Abstract][Full Text] [Related]
15. Patient health status and costs in heart failure: insights from the eplerenone post-acute myocardial infarction heart failure efficacy and survival study (EPHESUS).
Chan PS; Soto G; Jones PG; Nallamothu BK; Zhang Z; Weintraub WS; Spertus JA
Circulation; 2009 Jan; 119(3):398-407. PubMed ID: 19139382
[TBL] [Abstract][Full Text] [Related]
16. Combined baseline and one-month changes in big endothelin-1 and brain natriuretic peptide plasma concentrations predict clinical outcomes in patients with left ventricular dysfunction after acute myocardial infarction: Insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study.
Olivier A; Girerd N; Michel JB; Ketelslegers JM; Fay R; Vincent J; Bramlage P; Pitt B; Zannad F; Rossignol P;
Int J Cardiol; 2017 Aug; 241():344-350. PubMed ID: 28284500
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of matrix metalloproteinase-9 plasma levels to identify patients with preserved left ventricular systolic function after acute myocardial infarction who could benefit from eplerenone.
Kampourides N; Tziakas D; Chalikias G; Papazoglou D; Maltezos E; Symeonides D; Konstantinides S
Am J Cardiol; 2012 Oct; 110(8):1085-91. PubMed ID: 22742718
[TBL] [Abstract][Full Text] [Related]
18. Opposite predictive value of pulse pressure and aortic pulse wave velocity on heart failure with reduced left ventricular ejection fraction: insights from an Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) substudy.
Regnault V; Lagrange J; Pizard A; Safar ME; Fay R; Pitt B; Challande P; Rossignol P; Zannad F; Lacolley P
Hypertension; 2014 Jan; 63(1):105-11. PubMed ID: 24126172
[TBL] [Abstract][Full Text] [Related]
19. Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk.
Kosiborod M; Inzucchi SE; Krumholz HM; Xiao L; Jones PG; Fiske S; Masoudi FA; Marso SP; Spertus JA
Circulation; 2008 Feb; 117(8):1018-27. PubMed ID: 18268145
[TBL] [Abstract][Full Text] [Related]
20. [Effect of admission blood glucose levels on the short term mortality in patients with acute ST-segment elevation myocardial infarction].
Yang YM; Liu Y; Zhu J; Tan HQ; Liang Y; Li Y; Li JD; Zhang Y; Liu LS
Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1230-3. PubMed ID: 19595174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
